相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?
Jean-Philippe Lanoix et al.
CLINICAL INFECTIOUS DISEASES (2016)
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Alexander S. Pym et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
Simon Tiberi et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Ending tuberculosis by 2030: can we do it?
A. B. Suthar et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis
Jingtao Gao et al.
BMC PULMONARY MEDICINE (2016)
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
Riya Moodley et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Daily Rifapentine for Treatment of Pulmonary Tuberculosis A Randomized, Dose-Ranging Trial
Susan E. Dorman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis
Gwenan M. Knight et al.
CLINICAL INFECTIOUS DISEASES (2015)
Safety and Tolerability Profile of Second-Line Anti-Tuberculosis Medications
Geetha Ramachandran et al.
DRUG SAFETY (2015)
Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients
Jennifer Hughes et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Reducing relapse in tuberculosis treatment: is it time to reassess WHO treatment guidelines?
James C. Johnston et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
Rodney Dawson et al.
LANCET (2015)
WHO's new End TB Strategy
Mukund Uplekar et al.
LANCET (2015)
Pharmacological Interactions Between Rifampicin and Antiretroviral Drugs: Challenges and Research Priorities for Resource-Limited Settings
Hadija H. Semvua et al.
THERAPEUTIC DRUG MONITORING (2015)
Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study
Louis Grandjean et al.
PLOS MEDICINE (2015)
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
Emily A. Kendall et al.
LANCET RESPIRATORY MEDICINE (2015)
Tuberculosis treatment and management-an update on treatment regimens, trials, new drugs, and adjunct therapies
Alimuddin Zumla et al.
LANCET RESPIRATORY MEDICINE (2015)
Challenges of antituberculosis treatment in patients with difficult clinical conditions
Martina Vasakova
CLINICAL RESPIRATORY JOURNAL (2015)
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis
Kuldeep Singh Sachdeva et al.
PLOS ONE (2015)
Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
J. Peter Cegielski et al.
CLINICAL INFECTIOUS DISEASES (2014)
Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimens
E. Gospodarevskaya et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients
K. J. M. Aung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
Corinne S. Merle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Stephen H. Gillespie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
Vija Skripconoka et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
The High Cost of Free Tuberculosis Services: Patient and Household Costs Associated with Tuberculosis Care in Ebonyi State, Nigeria
Kingsley N. Ukwaja et al.
PLOS ONE (2013)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja et al.
PLOS MEDICINE (2012)
The impact of HIV/AIDS on the control of tuberculosis in India
BG Williams et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis
D Yee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
分享论文
